Summary
- Current Price
- As of today, GMED price is $85.90, down -0.05% on
- Current Price All-Time High
- GMED price is currently -15.29% below its historical high of $101.40 set on
- Market Cap
- GMED current market cap is $12B, up +42.28% over the past 365 days
- PE Ratio
- GMED current PE ratio is 21.96
- Revenue
- GMED current annual revenue is $2.94B, up +16.65% year-over-year
- Next Earnings
- The next earnings release for GMED is on
Profile
| Metric | Value |
|---|---|
| Full Name | Globus Medical, Inc. |
| Ticker | NYSE: GMED |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | globusmedical.com |
| Employees | 5,300 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $85.90 | |
| Price, 1D Change | -0.05% | |
| Market Cap | $12B | |
| - | ||
| PE Ratio | 21.96 | |
| Beta | 0.79 | |
| Revenue | $2.94B | |
| Revenue, 1Y Change | +16.65% | |
| EPS | $3.92 | |
| EPS, 1Y Change | +425.35% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $3.92 | |
| EPS Estimate | $4.98 | N/A |
| EPS Est. Change | +26.93% | N/A |
| Revenue | $2.94B | |
| Revenue Estimate | $3.20B | N/A |
| Revenue Est. Change | +8.87% | N/A |
| Current Price | $85.90 | |
| Price Target | $100.00 | - |
| Price Tgt. Change | +16.41% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.99 | $0.75 | -75.00% | |
| $3.86 | $3.92 | +1.73% | |
| $4.98 | N/A | +26.93% | |
| $5.36 | N/A | +36.68% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.51B | $2.52B | +0.44% | |
| $2.91B | $2.94B | +0.89% | |
| $3.20B | N/A | +8.87% | |
| $3.39B | N/A | +15.40% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +43.12% | |
| Price, 3Y | +49.42% | |
| Market Cap, 1Y | +42.28% | |
| Market Cap, 3Y | +99.73% | |
| Revenue, 1Y | +16.65% | |
| Revenue, 3Y | +187.33% | |
| EPS, 1Y | +425.35% | |
| EPS, 3Y | +111.82% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $85.90 | |
| SMA 200 | $84.97 | |
| SMA 50 | $79.86 | |
| EMA 200 | $81.09 | |
| EMA 50 | $81.14 | |
| MACD | $1.69 | |
| Beta | 0.79 | |
| ATR | $2.95 | |
| 14-Day RSI | 63.20 | |
| 10-Day Volatility | 31.73% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $2.94B | |
| EPS | $3.92 | |
| Gross Profit | $1.86B | |
| Gross Margin | 63.39% | |
| Operating Income | $540.76M | |
| Operating Margin | 18.40% | |
| Net Income | $537.87M | |
| Net Margin | 18.30% | |
| EBITDA | $818.24M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.03 | |
| 4.26 | ||
| 2.74 | ||
| - | ||
| 8 | ||
| 11.11 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 21.96 | |
| 3.67 | ||
| 2.42 | ||
| 11.53 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $4.57B | |
| $557.24M | ||
| $5.30B | ||
| $2.13B | ||
| $729.51M | ||
| $498.50M | ||
| Total Debt | $119.44M | |
| $15.09M | ||
| $98.85M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $2.40B | ||
| $1.32B | ||
| $1.08B | ||
| $0.00 | ||
| $276.84M | ||
| $0.00 | ||
| $67.20M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $753.45M | ||
| -$355.01M | ||
| -$679.16M | ||
| Capex | $174.43M | |
| $579.02M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wells Fargo | → | |
| UBS | ||
| Truist Securities | → | |
| RBC Capital | → | |
| BMO Capital | ||
| Stifel | → | |
| Piper Sandler | → | |
| Wells Fargo | → | |
| RBC Capital | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
Screeners with GMED
FAQ
- What is the ticker symbol for Globus Medical, Inc.?
- The ticker symbol for Globus Medical, Inc. is NYSE:GMED
- Does Globus Medical, Inc. pay dividends?
- No, Globus Medical, Inc. does not pay dividends
- What sector is Globus Medical, Inc. in?
- Globus Medical, Inc. is in the Healthcare sector
- What industry is Globus Medical, Inc. in?
- Globus Medical, Inc. is in the Medical Devices industry
- What country is Globus Medical, Inc. based in?
- Globus Medical, Inc. is headquartered in United States
- When did Globus Medical, Inc. go public?
- Globus Medical, Inc. initial public offering (IPO) was on August 3, 2012
- Is Globus Medical, Inc. in the S&P 500?
- No, Globus Medical, Inc. is not included in the S&P 500 index
- Is Globus Medical, Inc. in the NASDAQ 100?
- No, Globus Medical, Inc. is not included in the NASDAQ 100 index
- Is Globus Medical, Inc. in the Dow Jones?
- No, Globus Medical, Inc. is not included in the Dow Jones index
- When was Globus Medical, Inc. last earnings report?
- Globus Medical, Inc.'s most recent earnings report was on August 6, 2026
- When does Globus Medical, Inc. report earnings?
- The next expected earnings date for Globus Medical, Inc. is November 5, 2026
Data Sources & References
- GMED Official Website www.globusmedical.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1237831/000162828026011209/0001628280-26-011209-index.htm
- GMED Profile on Yahoo Finance finance.yahoo.com/quote/GMED
- GMED Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gmed